Know Cancer

or
forgot password

The Character of Perfusion Parameters Derived From MDCT Between Adenocarcinoma and Squamous Cell Carcinoma of Lung in the Treatment Course of Radiation Therapy


N/A
18 Years
N/A
Open (Enrolling)
Both
Adenocarcinoma, Squamous Cell Carcinoma, Relevant Condition Terms to the Conditions Field

Thank you

Trial Information

The Character of Perfusion Parameters Derived From MDCT Between Adenocarcinoma and Squamous Cell Carcinoma of Lung in the Treatment Course of Radiation Therapy


Inclusion Criteria:



- Ages 18 and up

- Males and females

Exclusion Criteria:

- Pregnancy

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

This study will provide information of quantitative measurement of lung cancer, in term of tumor permeability (mL/100 mL/min) and blood volume (mL/100 mL), in addition to tumor size.

Outcome Time Frame:

Dec, 2008

Safety Issue:

Yes

Principal Investigator

Yeun-Chung Chang, Ph.D

Investigator Role:

Principal Investigator

Investigator Affiliation:

National Taiwan University Hospital

Authority:

Taiwan: National Bureau of Controlled Drugs

Study ID:

200705059R

NCT ID:

NCT00751543

Start Date:

January 2008

Completion Date:

Related Keywords:

  • Adenocarcinoma
  • Squamous Cell Carcinoma
  • Relevant Condition Terms to the Conditions Field
  • To evaluate the longitudinal change of tumor perfusion in the course of radiation therapy in adenocarcinoma and squamous cell carcinoma using perfusion MDCT
  • Comparison between adenocarcinoma and squamous cell carcinoma will be evaluated according to the derived perfusion parameter obtained from perfusion MDCT
  • Adenocarcinoma
  • Adenocarcinoma, Mucinous
  • Carcinoma
  • Carcinoma, Squamous Cell
  • Lung Neoplasms

Name

Location